If youre a payer, employer or provider navigating the GLP-1 revolution, dont rely solely on published trials
In the clinical trial, the 8mg group showed 22.8% average weight loss, which is still higher than any other weight loss medication at its maximum dose
The third, glucagon , contributes to blood sugar management
The combination of adequate B12 with microdose tirzepatide supports the neurological aspects of longevity protocols specifically
State Level Medicaid Budgets : States with high obesity and diabetes prevalence, such as Mississippi and West Virginia, could face disproportionate budget impacts, with projected increases in Medicaid drug spending annually
PlexusDx supports patients seeking GLP-1 access by offering compounded options at predictable costs and providing genetic context about individual peptide pathway predispositions that may help facilitate more informed conversations with healthcare providers